Answers are grounded in this paper and cite their sources.
Effective surface functionalization is a key requirement for the application of nanoparticles in biomedicine. Protein-based coatings offer a versatile solution, providing abundant functional groups, colloidal stabilization, and a well-established basis for bioconjugation. This review examines desolvation as a method for encapsulating nanoparticles within covalently cross-linked protein matrices, yielding nanocomposites that can contain multiple nanoparticles within a single protein carrier. Although desolvation is widely used to prepare drug-loaded nanocarriers, this review considers it from a different perspective, focusing on its potential for preparing nanocomposites for biosensing. Analysis of the literature demonstrates that desolvation is a versatile approach capable of encapsulating nanoparticles of different sizes, structures, and surface chemistries. It enables the preparation of nanocomposite labels with unique combinations of properties for prospective analytical applications, including surface-enhanced Raman scattering, magnetic, fluorescence, Förster resonance energy transfer, catalytic, and stimulus-responsive systems. Desolvation-derived nanocomposites can exhibit good short- and long-term stability and can be produced at tens-of-grams scale under laboratory conditions. Potential sources of irreproducibility in desolvation and non-specific interactions arising from the cross-linked protein matrix are also discussed. By linking the synthesis of protein–nanoparticle composites to the requirements of diagnostic assays, this review outlines how desolvation-based nanocomposites may serve as practical multilabel reagents for established and emerging bioanalytical formats.
No takes yet. Share an insight, caveat, or question.
Khramtsov et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: